fbpx

New cancer research facility aims to accelerate personalised cancer medicine in Queensland

Diamantina_Opening_2The opening of a new cancer genomics centre at UQ Diamantina Institute at TRI means Queensland is now home to the largest and most sophisticated genome sequencing facility in the southern hemisphere.

Funded by the ACRF ($2 million), the Diamantina Individualised Oncology Care Centre (DIOCC) will be an innovative, world leading center of near-patient cancer genomics research.

“The way forward for cancer research is to really prioritise translational, patient-focused outcomes, and that is why the Australian Cancer Research Foundation is so proud to support this new centre at TRI,” said ACRF Chairman, Mr Tom Dery.

DIOCC will house state of the art genomics, proteomics and metabolomics technology. This technology will enable cutting edge research primarily into skin, blood and breast cancers.

The research to be undertaken within DIOCC will focus on understanding disease causes, improving diagnosis and treatment development. It will also allow for the development of protocols to implement the use of these new technologies in clinical practice.

As a collaboration of clinicians and scientists working in near patient cancer research, DIOCC offers a unique opportunity to foster translational research.

It brings together research and clinical groups across the Princess Alexandra Hospital (PAH) campus, including clinical services in Oncology, Haematology and Dermatology, The University of Queensland Schools of Medicine and Pharmacy and the Translational Research Institute (TRI).

The new facility was opened during an official ceremony on Thursday 31 July 2014.[/vc_column_text][/vc_column][/vc_row][vc_gallery type=”flexslider_fade” interval=”0″ images=”22170,22167,22172,22168,22171,22169″ onclick=”link_image” custom_links_target=”_self” img_size=”large”][/vc_column][/vc_row]

$7.5 million in funding to the most promising cancer research in the country!

Funding research - current cancer researchThe Australian Cancer Research Foundation is committed to fighting cancer by funding research, tonight investing a further $7.5 million into the search for the cures.

At the cancer charity’s annual Chairman’s Dinner in Sydney, donors, fundraisers and researchers came together to celebrate the incredible research outcomes made possible through ACRF funding.

They also acknowledged the promising future of cancer research in Australia, as the ACRF made multi-million dollar grants available to three visionary research projects.

The Peter MacCallum Cancer Centre in Melbourne, and Brisbane’s Diamantina Institute and Centre for Clinical Research all received a significant funding boost of $3.5 million and $2 million each, respectively. At these cancer research centres, the ACRF will be funding research into rare cancers, as well as facilitating world-class, targeted detection and treatment programmes.

Five of Australia’s best cancer research initiatives in the running for ACRF grants!

The ACRF was thrilled to recently receive 12 applications for our cancer research grants in 2012, representing a need for $41.7 million.

These applications have since been reviewed by our esteemed, independent Medical Research Advisory Committee and a shortlist of five fantastic initiatives has been identified for further assessment.

Each application presents an impressive, visionary project – three of which have been submitted by research centres in Brisbane with one more in each of Sydney and Melbourne.

Each research centre has been invited to submit a follow-up application containing further detail about their research projects, with site visits to be conducted by the Medical Research Advisory Committee in October. The final grant awardees will be announced at our annual Chairman’s Dinner in November 2012.

Centre for Clinical Research, University of Queensland, Brisbane

The UQ Centre for Clinical Research has applied for funding to purchase one of the first commercially available clinical (human) MRI/PET scanners. This application aims to establish a single site facility for clinical oncology imaging with hybrid molecular imaging technology. Continue reading “Five of Australia’s best cancer research initiatives in the running for ACRF grants!”

ACRF announces its cancer research grants shortlist

ACRF cancer research grantsFive of Australia’s best cancer research initiatives are in the running to receive a multi-million dollar grant from the Australian Cancer Research Foundation in 2012.

After an extensive review process, the final grant awardees will be announced at the ACRF’s annual Chairman’s Dinner in November. Continue reading “ACRF announces its cancer research grants shortlist”

Two world-class research centres to open in QLD

Mr Tom S DeryI’m thrilled to announce the official openings of two world-class cancer research laboratories in Queensland next Tuesday [19 July, 2011]:

It is a true mark of the superior research being undertaken in the Sunshine State that these laboratories are opening on the same day to guests from all over the country.

In 2007 ACRF provided $2.7 million and $3.2 million respectively in seed funding to establish both of these facilities. Less than four years later, the labs are operating, and more importantly, they are making significant breakthroughs in our understanding of cancer and the ways we can prevent, diagnose, treat and defeat this terrible disease. Continue reading “Two world-class research centres to open in QLD”

Professor Ian Frazer elected Fellow of The Royal Society

Chairman of the ACRF Medial Research Advisory Committee, Professor Ian Frazer, has been appointed a Fellow of the esteemed Royal Society of London for his ground-breaking research that resulted in a vaccine for cervical cancer.

The 350 year old scientific academy acknowledges some of the most distinguished scientists in the world, with current and previous Fellows including Michael Faraday, Stephen Hawking and Isaac Newton.

“Election to The Royal Society is a great and unexpected honor, providing an opportunity to interact with the world’s leading scientists,” Professor Frazer said. Continue reading “Professor Ian Frazer elected Fellow of The Royal Society”